These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18335390)

  • 1. [Pathophysiology of myocardial reperfusion injury].
    Piper HM; Kasseckert SA; Schlüter KD; Abdallah Y
    Dtsch Med Wochenschr; 2008 Mar; 133(12):586-90. PubMed ID: 18335390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signalling pathways in ischaemic postconditioning.
    Hausenloy DJ
    Thromb Haemost; 2009 Apr; 101(4):626-34. PubMed ID: 19350104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium-mediated cell death during myocardial reperfusion.
    Garcia-Dorado D; Ruiz-Meana M; Inserte J; Rodriguez-Sinovas A; Piper HM
    Cardiovasc Res; 2012 May; 94(2):168-80. PubMed ID: 22499772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits of reperfusion beyond infarct size limitation.
    Takemura G; Nakagawa M; Kanamori H; Minatoguchi S; Fujiwara H
    Cardiovasc Res; 2009 Jul; 83(2):269-76. PubMed ID: 19176600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The first minutes of reperfusion: a window of opportunity for cardioprotection.
    Piper HM; Abdallah Y; Schäfer C
    Cardiovasc Res; 2004 Feb; 61(3):365-71. PubMed ID: 14962469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular unloading before reperfusion reduces endothelin-1 release and calcium overload in porcine myocardial infarction.
    Tamareille S; Achour H; Amirian J; Felli P; Bick RJ; Poindexter B; Geng YJ; Barry WH; Smalling RW
    J Thorac Cardiovasc Surg; 2008 Aug; 136(2):343-51. PubMed ID: 18692640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process.
    Moens AL; Claeys MJ; Timmermans JP; Vrints CJ
    Int J Cardiol; 2005 Apr; 100(2):179-90. PubMed ID: 15823623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orphan targets for reperfusion injury.
    Inserte J; Barrabés JA; Hernando V; Garcia-Dorado D
    Cardiovasc Res; 2009 Jul; 83(2):169-78. PubMed ID: 19351740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcoplasmic reticulum-mitochondrial interaction in the mechanism of acute reperfusion injury. Viewpoint.
    Piper HM; Abdallah Y; Kasseckert S; Schlüter KD
    Cardiovasc Res; 2008 Jan; 77(2):234-6. PubMed ID: 18006433
    [No Abstract]   [Full Text] [Related]  

  • 10. Lethal myocardial reperfusion injury: a necessary evil?
    Ibanez B; Fuster V; Jiménez-Borreguero J; Badimon JJ
    Int J Cardiol; 2011 Aug; 151(1):3-11. PubMed ID: 21093938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Using marker of the mitochondrial pore opening in diagnostics of patients with myocardial ischemic lesions].
    Sahach VF; Dmytriieva AV; Bubnova IuO; Maksymenko VB; Knyshov HV
    Fiziol Zh (1994); 2009; 55(1):12-8. PubMed ID: 19441710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioids and myocardial reperfusion injury.
    Gross GJ; Peart JN
    Arch Mal Coeur Vaiss; 2007 Mar; 100(3):231-7. PubMed ID: 17536429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial protection during reperfusion.
    Piper HM; Siegmund B; Ladilov YV; Schlüter KD
    Thorac Cardiovasc Surg; 1996 Feb; 44(1):15-9. PubMed ID: 8721395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial protection against reperfusion injury: the cGMP pathway.
    Garcia-Dorado D; Agulló L; Sartorio CL; Ruiz-Meana M
    Thromb Haemost; 2009 Apr; 101(4):635-42. PubMed ID: 19350105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sarcoplasmic reticulum as the primary target of reperfusion protection.
    Piper HM; Kasseckert S; Abdallah Y
    Cardiovasc Res; 2006 May; 70(2):170-3. PubMed ID: 16600194
    [No Abstract]   [Full Text] [Related]  

  • 16. Limitation of infarct size by erythropoietin is associated with translocation of Akt to the mitochondria after reperfusion.
    Kobayashi H; Miura T; Ishida H; Miki T; Tanno M; Yano T; Sato T; Hotta H; Shimamoto K
    Clin Exp Pharmacol Physiol; 2008 Jul; 35(7):812-9. PubMed ID: 18346168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New pharmacologic options in the treatment of acute coronary syndromes and myocardial ischemia-reperfusion injury: potential role of levosimendan.
    Garcia-Gonzalez MJ; Dominguez-Rodriguez A; Abreu-Gonzalez P
    Minerva Cardioangiol; 2007 Oct; 55(5):625-35. PubMed ID: 17912166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology of the no-reflow phenomenon.
    Vrints CJ
    Acute Card Care; 2009; 11(2):69-76. PubMed ID: 19526383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of mitochondrial permeability transition pore opening: translation to patients.
    Gomez L; Li B; Mewton N; Sanchez I; Piot C; Elbaz M; Ovize M
    Cardiovasc Res; 2009 Jul; 83(2):226-33. PubMed ID: 19221132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 2 ryanodine receptor: a novel therapeutic target in myocardial ischemia/reperfusion.
    Fauconnier J; Roberge S; Saint N; Lacampagne A
    Pharmacol Ther; 2013 Jun; 138(3):323-32. PubMed ID: 23384595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.